Research Department

About Us

The Omaha Insomnia Research Department actively participates in research studies and is currently seeking qualified individuals to join our efforts in advancing science and medicine for those impacted by a spectrum of mental health disorders, including bipolar disorder, schizophrenia, tardive dyskinesia, and others. Our primary objective is to evaluate treatment outcomes and determine the safety and tolerance levels of various options. Research provides access to innovative treatments for diverse mental health conditions when traditional methods prove inadequate. Participants are usually compensated for their time and travel, and they receive study medication and devices at no cost.


Participating in our research studies offers several benefits. Firstly, you receive compensation from our research sponsors for your time and effort. Additionally, you have access to certain healthcare benefits, including study medication, at no cost to you. Beyond tangible rewards, there's a sense of fulfillment in knowing that you've contributed to something meaningful. By joining our studies, you not only help advance scientific knowledge but also potentially improve your own health outcomes and those of others facing similar challenges.

Study #11

Indication: Schizophrenia 

New Investigational Product: exploratory on perceptions and preferences of Long Acting Injectables

Age:

Compensation: $75

Study #10

Indication: Schizophrenia 

New Investigational Product: exploratory

Age:

Compensation: $75

Study #9

Indication: Schizophrenia 

New Investigational Product: exploratory

Age:

Compensation: $50

Study #8

Indication:  Bipolar Disorder I

This is a registry study with no age requirement. 

Age: 

Compensation: up to $75 patient 

Study #7

Indication:  Tardive Dyskinesia

This is a registry study. 

Age:  1≥18 years old

Compensation: up to $75 patient stipend per visit 

Study #6

Indication: Major Depressive Disorder

New Investigational Product:

Age:

Compensation: $100

Study #5

Indication:  Bipolar Disorder I

This is a registry study with no age requirement. 

Age: 

Compensation: up to $75 patient 

Study #4

Indication:  Tardive Dyskinesia

This is a registry study. 

Age:  1≥18 years old

Compensation: up to $75 patient stipend per visit 

Study #3

Indication:  Schizophrenia 

New Investigational Product: CT-155

Age: 

Compensation: up to $200 patient stipend 

Study #2

Indication:  Schizophrenia 

New Investigational Product :

Age:  ≥18 to <60

Compensation: up to $400 patient stipend and $150 study partner stipend per visit 

Study #1

Indication: Schizophrenia 

New Investigational Product :

Age: 18 to 50 years old

Compensation: up to $250 patient stipend and $150 study partner stipend per visit 

Join a Study?

If you believe you meet the criteria for our research studies, please complete the form below. Once submitted, it will be forwarded to us for review. If you meet the qualifications for the study, a member of our team will reach out to you regarding the next steps.

Contact Us